Key facts
- It has raised $3.2M; the latest was Seed Round ($3.2M) in Mar 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Biofractal (Enterprise Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Biofractal (Enterprise Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biofractal (Enterprise Systems)
Operator of a precision nutrition and health platform designed to improve profitability and sustainability in animal protein production. The company offers advanced gene expression technologies combined with AI to detect and resolve sub-clinical issues, enabling producers to optimize animal health and productivity.
- Sector
- Business Products and Services (B2B)
- HQ
- Loule, Portugal
- Founded
- 2020
- Employees
- 4
- Website
- biofractal.ai/
- Ownership
- Privately Held (backing)
Biofractal (Enterprise Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biofractal (Enterprise Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biofractal (Enterprise Systems) in its N-PORT filings yet. We sweep new filings monthly.